Category Archives: Neuroscience

The Neuroscience of Why You Could Really Use a Hug Right Now – WIRED

Alice,* a 31-year-old director from London, has been breaking the coronavirus lockdown rules. I almost dont want to tell you this, she says, lowering her voice. Her violation? Once a week, Alice, who lives alone, walks to the end of her garden to meet her best friend Lucy.* There, with the furtiveness of a street drug deal, Lucy hugs her tightly. Alice struggles to let her go. You just get that rush of feeling better, Alice says. Like its all OK.

Wired UK

This story originally appeared on WIRED UK.

Aside from Lucys hugs, Alice hasnt been touched by another person since March 15, which is when she went into a self-imposed lockdown, a week before the official government advice to self-isolate. Ive found it really hard, she says. I am a huggy person. You start to notice it after a while. I miss it. She feels guilty about her surreptitious hugs. I feel like I cant tell my other friends about it, Alice says. Theres a lot of shaming going on. I know we arent meant to. But I am so grateful to her for checking in on me. It gives me such a lift.

Alice is experiencing the neurological phenomenon of "skin hunger," supercharged by the coronavirus pandemic. Skin hunger is the biological need for human touch. Its why babies in neonatal intensive care units are placed on their parents naked chests. Its the reason prisoners in solitary confinement often report craving human contact as ferociously as they desire their liberty.

When you touch the skin, explains Tiffany Field of the Touch Research Institute at the University of Miami, it stimulates pressure sensors under the skin that send messages to the vagus [a nerve in the brain]. As vagal activity increases, the nervous system slows down, heart rate and blood pressure decrease, and your brain waves show relaxation. Levels of stress hormones such as cortisol are also decreased. Touch also releases oxytocin, the hormone released during sex and childbirth to bond us together. In other words, human touch is biologically good for you. Being touched makes humans feel calmer, happier, and more sane.

Without touch, humans deteriorate physically and emotionally. We know from the literature that lack of touch produces very negative consequences for our well-being, says Alberto Gallace, a neuroscientist at the University of Milano-Bicocca. He explains that humans are inherently social creatures; studies have shown that depriving monkeys of physical contact leads to adverse health outcomes. Our brains and nervous systems are designed to make touch a pleasant experience, he says. Nature designed this sensory modality to increase our feelings of well-being in social environments. Its only present in social animals that need to be together to optimize their chances of survival.

Before the coronavirus pandemic, many developed nations were already at risk of becoming touch-free zones, with no-touch policies now common in schools and public institutions, for safeguarding and litigation reasons. Fields Touch Research Institute has been working on a global airport study to observe how much people touch each other while waiting to board flights. (The research is currently on pause.) We observed over 4,000 interactions, Field says. The data showed that, at least in public, there is virtually no touching98 percent of the time, people are on cell phones.

With social distancing protocols in place in countries across the world, those who live alone find themselves enduring months without human touch. This is a particularly cruel irony, given that skin hunger actually weakens our immune systemsmaking us potentially more susceptible to coronavirus. Im very concerned, says Field, because this is actually the time we need human touch the most. She explains that touch is instrumental in immune function because it reduces our cortisol levels. When cortisol levels are high, our immune system is depleted: Cortisol kills natural killer cells, a type of white blood cell that attacks viruses for us. Field says that human touch has been shown to increase natural killer cells in patients with HIV and cancer.

View post:
The Neuroscience of Why You Could Really Use a Hug Right Now - WIRED

Using Neuroscience to Evaluate and Guide Treatment for Pediatric Mood Disorders – A Free Webinar from the Brain & Behavior Research Foundation -…

New York, May 06, 2020 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation is hosting a free webinar Using Neuroscience to Evaluate and Guide Treatment for Pediatric Mood Disorders on Tuesday, May 12, 2020, from 2pm to 3pm ET. Manpreet Kaur Singh, M.D. M.S., Stanford University School of Medicine, Associate Professor of Psychiatry and Behavioral Sciences Director and 2016 Independent Investigator Grant recipient, will be the presenter.Research in early onset mood disorders is geared towards using neuroscience to develop interventions that alleviate symptoms, promote healthy brain development, and treat behavioral and emotional difficulties as soon as they arise. This webinar considers the promise of utilizing neuroscience tools to aim for reliable and lasting improvements in symptoms for a large number of children and adolescents who experience a broad spectrum of mood problems. The presentation considers the importance of understanding and leveraging the placebo effect and measuring mechanisms of change, both in the way that treatments are configured and in the way that future clinical trials are designed.Jeffrey Borenstein, M.D., President and CEO of the Brain & Behavior Research Foundation and Host and Executive Producer of the public television series Healthy Minds, will be the moderator. Join by phone or on the web at bbrf.org/maywebinar.

This webinar is part of a series of free monthly Meet the Scientist webinars on the latest developments in psychiatry offered by the Brain & Behavior Research Foundation. Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.

The Brain & Behavior Research Foundation The Brain & Behavior Research Foundation awards research grants to develop improved treatments, cures, and methods of prevention for mental illness. These illnesses include addiction, ADHD, anxiety, autism, bipolar disorder, borderline personality disorder, depression, eating disorders, OCD, PTSD, and schizophrenia, as well as research on suicide prevention. Since 1987, the Foundation has awarded more than $408 million to fund more than 4,800 leading scientists around the world, which has led to over $4 billion in additional funding. 100% of every dollar donated for research is invested in research grants. BBRF operating expenses are covered by separate foundation grants. BBRF is the producer of the Emmy nominated public television series Healthy Minds with Dr. Jeffrey Borenstein, which aims to remove the stigma of mental illness and demonstrate that with help, there is hope.

Attachment

Myrna MannersBrain & Behavior Research Foundation(718) 986-7255mmanners@mannersdotson.com

More:
Using Neuroscience to Evaluate and Guide Treatment for Pediatric Mood Disorders - A Free Webinar from the Brain & Behavior Research Foundation -...

Vanderbilt receives $20 million from The William K. Warren Foundation to further treatments for brain disorders – Vanderbilt University News

New gift establishes the Warren Center for Neuroscience Drug Discovery to support pharmaceutical breakthroughs

Vanderbilt University received $20 million from The William K. Warren Foundation, located in Tulsa, Oklahoma, to establish the Warren Center for Neuroscience Drug Discovery.

The Center for Neuroscience Drug Discovery, led by co-directors Craig Lindsley and Jeffrey Conn, currently includes approximately 100 renowned scientists with a diverse set of interests and skills working to translate essential research ideas into viable new drug treatments that prevent serious brain disorders, like Alzheimers, schizophrenia and Parkinsons disease.

One of the more promising compounds, VU319, developed by Vanderbilt researchers and sponsored by the Warren Foundation, could help slow memory loss accompanying various cognitive diseases. It recently went into human phase-1 FDA clinical trialsa unique accomplishment for an academic research program.

The Warren Foundation is a visionary organization dedicated to supporting scientific and medical research designed to treat and prevent some of the most tragic, vexing diseases known to humankind. Having the foundations imprimatur is truly a mark of distinction for Vanderbilt, said Susan R. Wente, interim chancellor and provost, as well as a leading cell biologist. We are honored by the Warren familys multigenerational support across many areas of our beloved university. This latest gift demonstrates, once again, their enduring commitment to improving the human condition.

The William K. Warren Foundation was founded in 1945 by oilman William Kelly Warren and his wife, Natalie Overall Warren, who graduated from Vanderbilt (1920) and shares that distinction with her father (1885) and her four siblings. The Warren Foundation established Oklahomas largest health care provider, the Saint Francis Health System, and the Laureate Institute for Brain Research in Tulsa. The Foundation supports health care innovation, medical research, Catholic initiatives, education and Tulsa-specific causes.

We have been impressed with the creative approaches and hard work demonstrated by Vanderbilt researchers, especially Craig and Jeff, in the Center for Neuroscience Drug Discovery, said John-Kelly Warren, CEO of the Warren Foundation and grandson of the founders. Supporting novel, research-based methods to combat devastating cognitive impairments and mental illnesses lies at the heart of our foundations mission. It is also gratifying to support this research at Vanderbilt University, an institution that has made a significant impact on the lives of so many, including my family.

In addition to supporting research efforts, part of the Warren gift will be used to create an endowment designed to encourage mentorship and the development of a long-term pipeline of research leaders.

Genuine breakthroughs sometimes require taking paths that may not seem promisingor at least commercially viablein the earliest stages of scientific investigation, said Craig Lindsley, who holds the William K. Warren, Jr. Chair in Medicine. The support of philanthropic organizations like the Warren Foundation is critical to making discoveries that may not otherwise see the light of day and translate them to the clinic.

Lawrence Marnett, dean of Basic Sciences in the School of Medicine and Mary Geddes Stahlman Professor of Cancer Research, said the Warren Foundation has been a steadfast partner to medical researchers at Vanderbilt and other esteemed institutions across the country.

It is gratifying to support this research at Vanderbilt University, an institution that has made a significant impact on the lives of so many, including my family.John-Kelly Warren

The basis of any remarkable scientific advancement begins first with unlocking fundamental knowledge, Marnett said. This work often takes years of patient, systematic trial and error. Yet, the ultimate benefit to society can be transformational. The Warren Foundation has understood and supported this belief for many yearsand I am grateful they are doing so once again with this most recent gift.

In addition to this latest commitment, the Warren Foundation has been a longstanding supporter of Vanderbilt and its Center for Neuroscience Drug Discovery. There are currently seven endowed faculty chairs supported by the foundationranging in disciplines from medicine and pediatrics to divinityas well as the William K. Warren Foundation Scholarship for deserving undergraduates in the College of Arts & Science.

Follow this link:
Vanderbilt receives $20 million from The William K. Warren Foundation to further treatments for brain disorders - Vanderbilt University News

Neuroscience Antibodies & Assays Market Future Growth by In Depth Industry Analysis, Size, Trends and Forecast to 2026 – Cole of Duty

Abcam

The scope of the Report:

The report analyzes the key opportunities, CAGR, and Y-o-Y growth rates to allow readers to understand all the qualitative and quantitative aspects of the Neuroscience Antibodies & Assays market. A competition analysis is imperative in the Neuroscience Antibodies & Assays market and the competition landscape serves this objective. A wide company overview, financials, recent developments, and long and short-term strategies adopted are par for the course. Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in the sales of Neuroscience Antibodies & Assays across the world has been calculated through primary and secondary research. The Neuroscience Antibodies & Assays Market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

By Regions:

* North America (The US, Canada, and Mexico)

* Europe (Germany, France, the UK, and Rest of the World)

* Asia Pacific (China, Japan, India, and Rest of Asia Pacific)

* Latin America (Brazil and Rest of Latin America.)

* Middle East & Africa (Saudi Arabia, the UAE, , South Africa, and Rest of Middle East & Africa)

To get Incredible Discounts on this Premium Report, Click Here @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=28342&utm_source=COD&utm_medium=005

Highlights of the Neuroscience Antibodies & Assays market study:

Speculations for sales:

The report contains historical revenue and volume that backing information about the market capacity, and it helps to evaluate conjecture numbers for key areas in the Neuroscience Antibodies & Assays market. Additionally, it includes a share of every segment of the Neuroscience Antibodies & Assays market, giving methodical information about types and applications of the market.

Key point summary of the Neuroscience Antibodies & Assays market report:

This report gives a forward-looking prospect of various factors driving or restraining market growth.

It presents an in-depth analysis of changing competition dynamics and puts you ahead of competitors.

It gives a six-year forecast evaluated on the basis of how the market is predicted to grow.

It assists in making informed business decisions by creating a pin-point analysis of market segments and by having complete insights of the Neuroscience Antibodies & Assays market.

This report helps users in comprehending the key product segments and their future.

Strategic Points Covered in TOC:

Chapter 1: Introduction, market driving force product scope, market risk, market overview, and market opportunities of the global Neuroscience Antibodies & Assays market

Chapter 2: Evaluating the leading manufacturers of the global Neuroscience Antibodies & Assays market which consists of its revenue, sales, and price of the products

Chapter 3: Displaying the competitive nature among key manufacturers, with market share, revenue, and sales

Chapter 4: Presenting global Neuroscience Antibodies & Assays market by regions, market share and with revenue and sales for the projected period

Chapter 5, 6, 7, 8 and 9: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions

Finally, the report global Neuroscience Antibodies & Assays market describes Neuroscience Antibodies & Assays industry expansion game plan, the Neuroscience Antibodies & Assays industry knowledge supply, appendix, analysis findings and the conclusion. It includes a through explanation of the cutting-edging technologies and investments being made to upgrade the existing ones.

Report customization:

Verified Market Research also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

Get Complete Report @ https://www.verifiedmarketresearch.com/product/Neuroscience-Antibodies-&-Assays-Market/?utm_source=COD&utm_medium=005

About us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyse data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defence, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080UK: +44 (203)-411-9686APAC: +91 (902)-863-5784US Toll Free: +1 (800)-7821768

Email: [emailprotected]

See the rest here:
Neuroscience Antibodies & Assays Market Future Growth by In Depth Industry Analysis, Size, Trends and Forecast to 2026 - Cole of Duty

Once homeless, USC Dornsife grad uses grit and determination to pursue his dreams > News > USC Dornsife – USC Dornsife College of Letters, Arts…

Tenacity and a belief in the power of education helped transfer student Nicholas Chapman build a better life for himself. He wants to become a doctor to give others the same chance. [4 min read]

After yet another morning tinged with the smell of whiskey and coffee on his fathers breath, Nicholas Chapman left home to live on the streets. He had finally had enough of the screaming matches, enough of the strict rules.

Chapman grabbed his cell phone. A friend gave him a backpack, $20, a change of clothes and some deodorant. With that, he became one of the thousands in Southern California who have no place to call home.

He was only 17.

But he felt hopeful. He was leaving an unhealthy environment, and he had a vague plan for his future: getting an education.

Eight years later, he is graduating from USC Dornsife College of Letters, Arts and Sciences and plans to become a doctor. His road to get here has been rocky. He just wants to do everything in his power to protect others from similar hardships.

I know how it is to almost fall through the cracks, the fear as if you will lose everything, Chapman said. I decided I didnt want to ever have anyone else have that feeling of losing their life, so conserving lives is my idea.

Early obstacles to a health care career

The 25-year-old graduates this month with a bachelors degree in neuroscience from USC Dornsife. Medical school is up next.

I want to put a mask on and help a person, then take the mask off and also help a person. Advocacy will always be a part of what I do.

Opening a hobby and gaming store in Long Beach helped Nicholas Chapman save enough to buy a car and rent an apartment. (Photo: Courtesy of Nicholas Chapman.)

Its a lesson he learned at a young age from his mother. The two left the United States for her native Brazil when Chapman was 2. She struggled to find work and would tell her young son that education was his best path out of poverty.

Seeing no way forward in Brazil, she encouraged him to return to the U.S. He moved in with his American father in Long Beach, California, at age 14.

Chapman had to learn to read and write in English as a teenager. He hid his struggles from teachers and peers, taking strategic bathroom breaks to avoid reading out loud in class.

Then there was the strained relationship with his dad, who is an alcoholic.

He also talks honestly about when he got caught sneaking out. His dad had grounded him already over another issue, and no end to the punishment was in sight. Chapman decided it was time he left for good.

I stayed in Metro stations. I stayed in homeless shelters. I stayed on friends couches, he said.

Although he had dropped out of high school, Chapman remembered his mothers advice: Get an education. He visited a $1 bookstore, where he pored over economics textbooks for hours. He earned his GED, then enrolled in classes at Long Beach City College.

He did well at first, but lack of sleep and the constant grind of day-to-day survival caught up quickly. His grades slipped. My 4.0 went to a 1.7, just like that, he said.

A mission to study medicine

Then at age 19, stability came in the form of a part-time job at a mom-and-pop hobby store. He sharpened his sales skills and soon became a manager. His grades recovered.

A year later, the store closed. But Chapman had saved some money and made friends with a few regular customers. They launched their own hobby shop, with Chapman as CEO. He soon could afford a car, then a rented room in an apartment.

Although he felt secure in his personal life, his business and economics classes left him uninspired. Then one day, the uncle of a boy he tutored had an epileptic seizure in front of his family and Chapman. Chapman felt shocked and helpless.

I went to that $1 bookstore, grabbed a human biology textbook and read all about the nervous system, he said. Thats when I started falling in love.

He switched his major from economics to psychology. He planned to transfer to the University of California system or USC, with the goal of applying to medical school. But his academic counselor said with the string of poor grades early in his college career, he had no chance.

Nicholas Chapman, 2nd from right, speaks during a panel for incoming transfer students at USC in 2018. (Photo: Eric Lindberg.)

Chapman applied anyway, relying on advice from a USC admissions adviser. He got into three UC schools and USC Dornsife, and he enrolled as a Trojan in Spring 2018.

Giving others a better life through medicine

Now, as he moves into the next phase of his life, with medical school planned for Fall 2021, Chapman took time to look back on his experiences.

My life has been about survival and lost innocence, he said. Working at Childrens Hospital, you see that same innocence diminish when kids realize they are going to die. Its the same innocence you see lost when a transfer student comes in and struggles. I lost that innocence at a young age, being on the streets.

If Chapman achieves his goal of becoming a doctor, he feels he will have gained resources and credibility that he can use to help others. And perhaps sharing his past will give someone the courage or persistence they need to survive.

Theres some kid out there on the streets crying in fear, or getting abused by their parents, or unable to have an education, he said. I want them to see my story and realize that they can push through, that they should conserve life and believe in themselves.

See USC News for more on the story >>

View original post here:
Once homeless, USC Dornsife grad uses grit and determination to pursue his dreams > News > USC Dornsife - USC Dornsife College of Letters, Arts...

Context is king in challenging COVID advertising landscape – AdNews

Getty

Timeliness, connection and trust are the most significant context attributes for trusted news environments, according to research testing COVID related content released by IAB Australia and neuroscience research firm Neuro-Insight.

The study of more than 900 Australians, assessed three different types of news content hard breaking news, COVID related updates and lifestyle content that is linked to our current COVID lockdown lives and explored how the attributes of these could help advertising messages take on additional meaning.

The study challenged the notion that advertisers need to develop new creative that directly or indirectly addresses COVID-19.

It found that while its important that advertisers are not tone deaf, that the news environments do some of the heavy lifting for the advertising messages in allowing marketing messages to achieve a certain amount of transferred equity that speaks to messages being timely.

IAB Australia CEO Gai Le Roysays with changes in third party cookies and increased privacy regulation around the world, the industry should be actively revisiting the power of context.

The importance and value of a thriving credible news environment is coming through loud and clear with increased audience numbers and engagement," Le Roy says.

"Last month we called on marketers to stop blocking advertising on essential news sites and we are now delivering research that provides marketers with proof that ads within news environments not only connect with engaged audiences it allows them to leverage the brand assets of the media environment as well.

Transferred equity of timeliness, connection and trust would be assets many brands would be seeking. This research shows that investing in news environments is not only good for society it is a smart brand investment."

The study also affirmed that increasing share of voice and having stronger associative factors with a media environment is incredibly powerful and is likely to weaken a competitor's attributes.

Neuro-Insight APAC CEO Peter Pyntasays the way media context influences ads is largely a subconscious process.

"We intuitively know its there, but its extremely difficult to articulate and measure through traditional means," Pynta says.

"Neuroscience is uniquely suited to capturing and measuring these effects through carefully designed studies which allow us to deliver a routine, objective measurement technique that can examine two crucial dimensions: the mediums context and its influence on advertising.

We believe this research can help identify new creative opportunities for marketers that offer an optimised brand fit between advertiser and media environment unlocking increased economic benefits through the advertising investment."

The research will be presented at a free webinar hosted by the IAB today. The full study will be available on the IAB website from Monday May 11, 2020.

The research was commissioned by IAB Australia following its call to marketers last month to support news environments that were investing in producing highly valued news and information.

Have something to say on this? Share your views in the comments section below. Or if you have a news story or tip-off, drop us a line at adnews@yaffa.com.au

Sign up to the AdNews newsletter, like us on Facebook or follow us on Twitter for breaking stories and campaigns throughout the day.

Visit link:
Context is king in challenging COVID advertising landscape - AdNews

Biological to Artificial and Back: How a Core AI Algorithm May Work in the Brain – Singularity Hub

Blame is the main game when it comes to learning.

I know that sounds bizarre, but hear me out. Neural circuits of thousands, if not more, neurons control every single one of your thoughts, reasonings, and behaviors. Take sewing a face mask as an example: somehow, a set of neurons have to link up in specific ways to make sure you dont poke your finger with a sharp needle. Youll fail at the beginning before getting better at protecting your hand while sewing uniform stitches with efficiency.

So the question is, of those neurons that eventually allow you to sew with ease, which onesor which connections between which oneswhere to blame initially for your injuries? Are those ones responsible for your eventual proficiency? How exactly does the brain learn through mistakes?

In a new paper, some of the brightest minds in AIincluding Dr. Geoffrey Hinton, the godfather of deep learning, and folks at DeepMind, the poster child of neuro-AI crossoversargue that ideas behind a core algorithm that drives deep learning also operate within the brain. The algorithm, called backpropagation, was the spark that fired up the current revolution of deep learning as the de facto machine learning behemoth. At its core, backprop is an extremely effective way to assign blame to connections in artificial neural networks and drive better learning outcomes. While theres no solid proof yet that the algorithm also operates in the brain, the authors laid out several ideas that neuroscientists could potentially test out in living brain tissue.

Its a highly controversial idea, partly because it was brought up years ago by AI researchers and refuted by neuroscientists as biologically impossible. Yet recently, the bond between deep learning techniques and neuroscience principles has become increasingly entangled in a constructive feedback circle of ideas. As the authors argue, now may be a good time to revisit the possibility that backpropagationthe heart of deep learningmay also exist in some form in biological brains.

We think that backprop offers a conceptual framework for understanding how the cortex learns, but many mysteries remain with regard to how the brain could approximate it, the authors conclude. If true, it means that somehow our biological brains came up with principles for designing artificial ones that, incredibly, loosely reflect evolutions slow sculpting of our own brains through genes. AI, the product of our brains, will amazingly become a way to understand a core mystery of how we learn.

The neuroscience dogma of learning in the brain is the idea of fire together, wire together. In essence, during learning, neurons will connect to each other through synapses into a network, which slowly refines itself and allows us to learn a tasklike sewing a mask.

But how exactly does that work? A neural network is kind of like a democracy with individuals who are only in contact with their neighbors. Any single neuron only receives input from its upstream partner, and passes along information to its downstream ones. In neuroscience parlance, how strongly these connections are depend on synaptic weightsthink of it as a firmer or looser handshake, or transfer of information. Stronger synaptic weight isnt always better. The main point of learning is to somehow tune the weights of the entire population so that the main outcome is the one we wantthat is, stitching cloths rather than pricking your finger.

Think of it as a voting scenario in which neurons are individual voters who are socially isolated and only in contact with their immediate neighbors. The community, as a whole, knows who they want to vote for. But then an opponent gets electedso the question is, where did things go awry, and how can the network as a whole fix it?

Its obviously not a perfect analogy, but it does illustrate the problem of assigning blame. Neuroscientists can generally agree that neural networks adjust synaptic weights of their neuron members to push the outcome towards something bettera process we call learning. But in order to adjust weights, first the network has to know which connections to adjust.

Enter backpropagation. In deep learning, which consists of multiple layers of artificial neurons connected to each other, the same blame problem exists. Back in 1986, Hinton and his colleagues David Rumelhart and Ronald Willliams found that as information travels across different neural layers, by observing how far the output misses its mark from the desired one, its possible to mathematically compute an error signal. This signal can then be passed back through the neural network layers, with each layer individually receiving a new error signal based on its upper layers. Hence, the name backpropagation.

Its kind of like five people passing each other a basketball in a line, and the last throw misses. The coachin this case, backpropagationwill start from the final player, judge how likely it was his or her problem, and move back down the line to figure out who needs adjustment. In an artificial neural network, adjustment means changing the synaptic weight.

The next step is for the network to compute the same problem again. This time around, the ball goes in. That means whatever adjustments the backprop coach made worked. The network will adopt the new synaptic weights, and the learning cycle continues.

Sound like a logical way of learning? Totally! Backprop, in combination with other algorithms, has made deep learning the dominant technique in facial recognition, language translation, and AIs wins against humans in Go and poker.

The reality is that in deep neural networks, learning by following the gradient of a performance measure works really well, the authors said. Our only other measure of efficient learning is our own brainso is there any chance that the ideas behind backprop also exist in the brain?

30 years ago the answer was a hell no. Many reasons exist, but a main one is that artificial neural networks arent set up the way biological ones are, and the way backprop mathematically works just cant literally translate to what we know about our own brains. For example, backprop requires an error signal to travel along the same paths as the initial feed-forward computationthat is, the information pathway that initially generated the resultbut our brains arent wired that way.

The algorithm also changes synaptic weights through a direct feedback signal. Biological neurons, in general, dont. They can change their connections through more input, or other types of regulationhormones, chemical transmitters, and whatnotbut using the same physical branches and synapses for both forward and feedback signals, while not getting them mixed up, was considered impossible. Add to that the fact that synapses are literally where our brains store data, and the problem becomes even more complicated.

The authors of the new paper have a rather elegant solution. The key is to not take backprop literally, but just adopt its main principles. Here are two as an example.

One, if the brain cant physically use feedback signals to change its synaptic weights, we do know that it uses other mechanisms to change its connections. Rather than an entire biological network using the final outcome to try to change synaptic weights at all levels, the authors argue, the brain could instead alter the ability of neurons to fireand in turn, locally change synaptic weights so that the next time around, you dont prick your finger. It may sound like nit-picking, but the theory changes something rather impossible in the brain to an idea that could work based on what we know about brain computations.

As for the problem of neural branches supporting both feedforward computing signals and feedback adjustment signals, the authors argue that recent findings in neuroscience clearly show that the neurons arent a uniform blob when it comes to computation. Rather, neurons are clearly divided into segments, with each compartment receiving different inputs and computing in slightly different ways. This means its not crazy to hypothesize that neurons can simultaneously support and integrate multiple types of signalsincluding error signalswhile maintaining their memory and computational prowess.

Thats the simple distillation. Many more details are explained in the paper, which makes a good read. For now, the idea of backprop-like signals in the brain remains a conjecture; neuroscientists will have to carry out wet lab experiments to see if empirical data supports the idea. If the theory actually plays out in the brain, however, its another layerperhaps an extremely fundamental onethat links biological learning with AI. It would be a level of convergence previously unimaginable.

Image Credit: Gerd Altmann from Pixabay

Read more:
Biological to Artificial and Back: How a Core AI Algorithm May Work in the Brain - Singularity Hub

Duke Faculty Reexamine Their Roles as Scholars and Mentors in an Uncertain Time – Duke Today

I've had so many people tell me over the last few weeks that they feel like theyre losing their identity, said Sherilynn Black, Associate Vice Provost for Faculty Advancement. The work that they dotheir teaching, research, scholarshipis so much of what makes them who they are.

Responding to the needs of faculty during the coronavirus pandemic, Black and her colleagues in Dukes Office of the Vice Provost for Faculty Advancement are adjusting their programming with topics ranging from virtual student engagement and mentoring, to specific challenges for assistant professors, to an end-of-semester faculty event and summer faculty book club.

On April 15, Black hosted an online workshop, Your Role as a Scholar and Mentor While Navigating the COVID-19 Crisis, for more than 125 people. Panelists were Sally Kornbluth, Provost and Jo Rae Wright University Distinguished Professor; Scott Huettel, Chair and Professor of Psychology and Neuroscience; Adriane Lentz-Smith, Associate Professor of History; and Nimmi Ramanujam, Robert W. Carr, Jr., Distinguished Professor of Biomedical Engineering.

Here are excerpts from the conversation:

Sally Kornbluth, Provost and Jo Rae Wright University Distinguished Professor:

I want to thank the faculty for their flexibility and adaptability in this crisis. The faculty have stepped up and done amazing things. We mounted more than 6,000 online courses [and] we have a very robust COVID-19-related research agenda going on. I think were calling on faculty to do a lot more things than we normally would.

Nimmi Ramanujam, Robert W. Carr, Jr., Distinguished Professor of Biomedical Engineering:

I went through the different stages of grief. In the beginning, I just didnt admit that Id have to have a new normal and a different pace. I feel uncomfortable because Im so used to go, go, go. The idea of actually pausing is incredibly hard, because thats not the norm and so it takes an effort. Theres a tremendous amount of inertia to switch gears, because weve been doing something a certain way for a very long time. I guess I'm recognizing that it does take some time to get to this new place.

Scott Huettel, Chair and Professor of Psychology and Neuroscience:

I think the biggest picture here is to recognize that you should be thinking very hard about what it means to be productive, and focus more on the intrinsic motivators to support your mental health and your own well-being. It doesnt do anyone any good to burn themselves out over the next month, if that is going to have long-term disadvantages for productivity over the next few years. Ive never heard from any administrator anything that prioritizes productivity over mental health and well-being. Put yourself first.

Adriane Lentz-Smith: Associate Professor of History

My entire family is in the house with me and theres a chance an eight-year-old is going to come bursting through the door. I cant write! In this immediate moment when everything is so higgledy-piggledy, I think pulling back, reading and settling into our thoughts have value. And Ive had my students say the same thing to me: Wow, we get much more out of this class when we actually have time to think about what youve assigned to us! For all of the talk of innovation and disruption and new, new, new, actually taking time to read and write and think and be critically engaged with the world around you is still at the heart of what we do and how we thrive.

Sally Kornbluth:

I would urge you as faculty not to create unrealistic expectations about your research agenda. Try to think about how you can keep moving it along, but it's not realistic to think that you're going to spend eight hours a day working on your book.

Nimmi Ramanujam:

Maybe one way to continue to be productive is to be really introspective. This is probably the first time I have lots of time to think. [Ive been] taking a step back and thinking about long-term goals as well as writing proposals that arent rushed. Ive been engaging students in the process of writing proposals and thinking about how to craft something from concept to a document that has some substance to it.

Sally Kornbluth:

Normally, we're all getting ready for a breather at this time of year. How do you think about a breather in the context of the pandemic? I dont think that people can sustain the incredible levels of work and momentum that we've seen over the last weeks, which were under an emergency situation. I encourage faculty to think about this.

Scott Huettel:

It is okay to take a deep breath. If one of my faculty members came to me and said, I can't do this service required for the next month because I have homeschooling on top of stress on top of eldercare, thats normal. Thats actually expected right now. You have a life outside of Duke. Let that be visible to others. Dont send signals that those things are secondary to productivity. Try to use this as a chance to humanize ourselves and be good role models for others in the community.

Nimmi Ramanujam:

I had initiated these undergraduate dinners recently [before social distancing, in person]. I didnt know if students would be interested to do this virtually [but I tried it]. It turned out that not only did the students that would normally show up come, but they had friends of friends of friends. They were asking questions that had nothing to do with their particular [academic] problems. They wanted to know what life is like from other perspectives, and so we ended up having a two-hour conversation. It seemed like very little effort, and it was therapeutic for me.

Adriane Lentz-Smith:

Im opening my classes by saying, Hows everybody doing? Who do you notice thats not here, and does anybody know why? I end by saying, I'm going to be around for five minutes after the lecture, so if you have something that you want to talk to me about, let me know. With graduate students, I said we should decide on a novel that we are all going to read and then convene at some point to talk about itnot a history monograph, and not to perform your intellect, but to just be like, Hey, I read this thing and I have some thoughts or ideas about it.

Scott Huettel:

Think of this next period as a time you get through. Stay as healthy and strong as possible. Draw insights from what youre learning over the next few weeks. As we come out of the immediate problems, the world will stabilize somewhat and then we're going to have opportunities for longer term planning.

Sally Kornbluth:

I think we have to allow ourselves to think really broadly about what we want the university to be 10 years from now. What would that look like if we were not constrained by our current organizational structures, by our current practices, etc.? How do we think about how we distribute resources? How do we think about our students? What kind of advice are we going to give to students who are entering a very different world? I would say there are no sacred cows here. In other words, we have to think broadly about what our priorities are, what we want to preserve going into the futurethings that may fundamentally alter the way we think about delivering our education and think about what really differentiates Duke.

Video footage and a transcript of this conversation will be posted on the website for the Office of the Vice Provost for Faculty Advancement.

See the article here:
Duke Faculty Reexamine Their Roles as Scholars and Mentors in an Uncertain Time - Duke Today

New therapeutic possibilities for treating intellectual disability in Down syndrome – News-Medical.Net

Reviewed by Emily Henderson, B.Sc.May 5 2020

A team of researchers led by Dr. Victoria Puig from the Hospital del Mar Medical Research Institute (IMIM), which also involved the Centre for Genomic Regulation (CRG), has studied the neural basis of intellectual disability in mice with Down syndrome and has discovered that the neural networks of brain circuits relevant to memory and learning are over-activated and that the connectivity of these circuits is poor.

The researchers have also observed that neural activity during sleep is abnormal and probably interferes with memory consolidation.

The study has even identified biomarkers in brain rhythms that can predict memory deficits in the mice which are corrected by chronic treatment with a natural component of green tea, epigallocatechin gallate, which other studies have already shown to improve executive function in adults with Down syndrome.

These results suggest that both hyperactivity of neuronal networks and deficiencies in the connectivity of specific brain circuits are possible dysfunctional mechanisms that contribute to memory deficits in Down syndrome and, therefore, offer new therapeutic possibilities for treating intellectual disability.

Dr. Victoria Puig, Researcher, Integrated Pharmacology and Systems Neuroscience Research Group, IMIM

To date, it had been recognized that epigallocatechin gallate corrects certain alterations at the molecular and cellular levels derived from the trisomy of chromosome 21 that are associated with cognitive deficits in Down syndrome.

However, a dynamic description of the actions of epigallocatechin gallate on neural activity during distinct brain states was lacking. This is, therefore, the first time that anyone has looked at how mouse brain responds to chronic treatment with epigallocatechin gallate at a functional level in trisomy conditions.

The study involved recording neuronal activity simultaneously in two brain regions critical for learning and memory, the prefrontal cortex and the hippocampus, in trisomic and non-trisomic mice during periods of rest while awake, asleep, and during the performance of a simple memory task.

The data was collected before and after one month of treatment with epigallocatechin gallate, and the alterations in the activity of the neuronal networks in the two regions as well as the connectivity of the circuitry correlating with memory capacities were analyzed and found to have been corrected with the green tea extract.

This study provides an in-depth description of the neurophysiological abnormalities present in different brain states in Down syndrome model mice and provides the keys for understanding the cellular mechanisms underlying the improved executive function observed in people with Down syndrome after chronic treatment with epigallocatechin gallate.

Dr. Mara Dierssen, Cellular and Systems Neurobiology Lab, Centre for Genomic Regulation

Dr. Maria Alemany, first author of the paper and also a researcher in the IMIM's Integrated Pharmacology and Neuroscience Systems research group, explains "that the group is evaluating the effects of cognitive stimulation during brain development on the neuronal activity of mice with Down syndrome. This is important for understanding the cellular mechanisms of cognitive stimulation that are normally used in people to improve intellectual disability."

Down syndrome is a genetic alteration produced by the presence of an extra copy of chromosome 21, which is why this syndrome is also known as trisomy 21. It is the main cause of intellectual disability and the most common human genetic alteration. It is estimated that 34,000 people with Down's syndrome live in Spain and that there are a total of six million sufferers worldwide.

This study provides an in-depth description of the neurophysiological abnormalities present in different brain states in Down syndrome model mice and provides the keys for understanding the cellular mechanisms underlying the improved executive function observed in people with Down syndrome after chronic treatment with epigallocatechin gallate.

Dr. Mara Dierssen, Cellular and Systems Neurobiology Lab, Centre for Genomic Regulation

Continued here:
New therapeutic possibilities for treating intellectual disability in Down syndrome - News-Medical.Net

BioXcel Therapeutics to Host First Quarter 2020 Operating and Financial Results Conference Call and Webcast – GlobeNewswire

NEW HAVEN, Conn., May 05, 2020 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (BTI or Company) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology, today announced it will host a conference call and webcast on Tuesday, May 12, 2020 at 8:30 AM Eastern Time to discuss its first quarter 2020 operating and financial results.

Conference Call & Webcast DetailsDate/Time: Tuesday, May 12, 2020, 8:30 AM Eastern TimeDomestic: 877-407-2985International: 201-378-4915The webcast will be accessible* under "Events" on the News & Media page of the Company's website at http://www.bioxceltherapeutics.com.

ReplayDomestic: 877-660-6853International: 201-612-7415Conference ID: 13703343*Replay available through May 26, 2020

About BioXcel Therapeutics, Inc.:

BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on drug development that utilizes artificial intelligence to identify improved therapies in neuroscience and immuno-oncology. BTI's drug re-innovation approach leverages existing approved drugs and/or clinically evaluated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. BTI's two most advanced clinical development programs are BXCL501, an investigational sublingual thin film formulation in development for acute treatment of agitation resulting from neuropsychiatric disorders, and BXCL701, an investigational orally administered systemic innate immunity activator in development for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer in combination with other immuno-oncology agents. For more information, please visit http://www.bioxceltherapeutics.com.

Contact Information:BioXcel Therapeutics, Inc.www.bioxceltherapeutics.com

Investor Relations:John Grazianojgraziano@troutgroup.com1.646.378.2942

Media:Julia Deutschjdeutsch@troutgroup.com1.646.378.2967

Read the original:
BioXcel Therapeutics to Host First Quarter 2020 Operating and Financial Results Conference Call and Webcast - GlobeNewswire